tAims: Evidence-based guidelines provide targets and performance measures for thetreatment of type 2 diabetic patients but a wide gap separates guidelines-driven recom-mendations from their clinical application, a phenomenon hindering the transfer of provenbenefits to affected populations.Methods: We analyzed the quality of diabetic care delivered by 8 general practitioners jointin a group practice attending 571 diabetic patients (5.6% of the total enlisted subjects) byassessing process (% of HbA1c, SBP and LDL-C determinations) and intermediate outcome (%of patients with HbA1c<7% vs >8%, systolic BP <130 mmHg vs >140 mmHg, LDL-cholesterol<100 mg/dL vs >130 mg/dL) indicators.Results: HbA1cwas at target in 49% of patients and >8% in 22%; SBP and LDL-C determinationwas available in about two-thirds of patients, only a minority at target for SBP and LDL-C.Antihyperglycemic and antihypertensive treatment was prescribed in most patients butonly a third was on statins. During the post-evaluation phase, percentages of patients withHbA1c>8%, SBP < 130 mmHg and LDL-C < 100 mg/dL and the drug prescription pattern didnot change.Conclusions: Several weaknesses affect primary care delivery to type 2 diabetic patients andefforts are needed to improve the management of this high-risk group.

Health care delivery in type 2 diabetes. A survey in an Italian primary care practice

PEDRINELLI, ROBERTO
2015

Abstract

tAims: Evidence-based guidelines provide targets and performance measures for thetreatment of type 2 diabetic patients but a wide gap separates guidelines-driven recom-mendations from their clinical application, a phenomenon hindering the transfer of provenbenefits to affected populations.Methods: We analyzed the quality of diabetic care delivered by 8 general practitioners jointin a group practice attending 571 diabetic patients (5.6% of the total enlisted subjects) byassessing process (% of HbA1c, SBP and LDL-C determinations) and intermediate outcome (%of patients with HbA1c<7% vs >8%, systolic BP <130 mmHg vs >140 mmHg, LDL-cholesterol<100 mg/dL vs >130 mg/dL) indicators.Results: HbA1cwas at target in 49% of patients and >8% in 22%; SBP and LDL-C determinationwas available in about two-thirds of patients, only a minority at target for SBP and LDL-C.Antihyperglycemic and antihypertensive treatment was prescribed in most patients butonly a third was on statins. During the post-evaluation phase, percentages of patients withHbA1c>8%, SBP < 130 mmHg and LDL-C < 100 mg/dL and the drug prescription pattern didnot change.Conclusions: Several weaknesses affect primary care delivery to type 2 diabetic patients andefforts are needed to improve the management of this high-risk group.
Modesti, A; Bartaloni, R; Bellagamba, F; Caglieri, R; Cenori, K; Ciampalini, G; Costagli, A; Galloni, V; Del Papa, C; Modesti, L; Dell'Omo, G; Pedrinelli, Roberto
File in questo prodotto:
File Dimensione Formato  
2014_Modesti A et al_Primary Care Diab.pdf

non disponibili

Tipologia: Altro materiale allegato
Licenza: Importato da Ugov Ricerca - Accesso privato/ristretto
Dimensione 524.67 kB
Formato Adobe PDF
524.67 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11568/465268
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact